Driehaus Capital Management LLC I Mab Transaction History

Driehaus Capital Management LLC

  • $9.13 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$45.28 - $74.5 $17.7 Million - $29.1 Million
-390,077 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$57.18 - $84.43 $569,398 - $840,753
-9,958 Reduced 2.49%
390,077 $28.3 Million
Q2 2021

Aug 16, 2021
BUY
$47.86 - $83.95 $19.1 Million - $33.6 Million
400,035 New
400,035 $33.6 Million

Others Institutions Holding IMAB

# of Institutions
45
Shares Held
16M
Call Options Held
11.9K
Put Options Held
3.5K
View Full List

About I-Mab

IMAB Quotes by TradingView
  • Ticker IMAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,098,800
  • Market Cap $130M
  • Description
  • I-Mab, a clinical stage biopharmaceutical company, discovers, develops, and commercializes biologics to treat cancer and autoimmune disorders. It is developing Felzartamab, a CD38 antibody that is in Phase 1b/2a for patients with membranous nephropathy; Eftansomatropin alfa, a long-acting human growth hormone, which has completed Phase 3 clinica...
More about IMAB
Track This Portfolio

Track Driehaus Capital Management LLC Portfolio

Follow Driehaus Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Driehaus Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email